反应详情

The title compound (37 mg, 17%) was prepared from [2-(7-Chloro-thieno[3,2-b]pyridin-2-yl)-4-methyl-thiazol-5-yl]-morpholin-4-yl-methanone and 5-Phenyl-1,2-dihydro-pyrazol-3-one by a procedure analogous to Example 16 1. C25H21N5O3S2: APCI m/z 503.5 (pos.); 1H NMR (CD3OD): δ 8.55 (d, 1H, J=5.8 Hz), 8.00 (s, 1H), 7.72 (d, 2H, J=7.1 Hz), 7.46 (t, 2H, J=7.1 Hz), 7.41 (t, 1H, J=7.1 Hz), 7.08 (d, 1H, J=5.8 Hz), 6.53 (s, 1H), 3.71–3.60 (bm, 8H), 2.46 (s, 3H) ppm.